Endogenous oestrogens and breast cancer risk in premenopausal and postmenopausal women

Steroids

Volumn 76, Issue 8, 2011, Pages 812-815

  Key, Timothy J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Androgens; Breast cancer; Insulin like growth factor I; Oestrogens; Prolactin

Indexed keywords

ANDROGEN; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; PROGESTERONE; PROLACTIN; SOMATOMEDIN C; TESTOSTERONE;

BREAST CANCER; CANCER RISK; CONFERENCE PAPER; DISEASE ASSOCIATION; ESTRADIOL BLOOD LEVEL; ESTROGEN BLOOD LEVEL; HUMAN; MENSTRUAL CYCLE; OBESITY; POSTMENOPAUSE; PREMENOPAUSE;

ANDROGENS; BREAST NEOPLASMS; ESTRADIOL; ESTROGENS; FEMALE; GONADAL STEROID HORMONES; HUMANS; INSULIN-LIKE GROWTH FACTOR I; NEOPLASMS, HORMONE-DEPENDENT; POSTMENOPAUSE; PREMENOPAUSE; PROLACTIN; RISK FACTORS;

EID: 79958766712     PISSN: 0039128X     EISSN: 18785867     Source Type: Journal    
DOI: 10.1016/j.steroids.2011.02.029     Document Type: Conference Paper

References (26)

1. Pike MC, Spicer DV, Dahmoush L, Press MF. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev 1993;15:17-35. (Pubitemid 23269068)
2. Key TJA, Pike MC. The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol 1988;24:29-43. (Pubitemid 18009332)
3. Endogenous Hormones and Breast Cancer Collaborative Group (Writing Group: Key TJ, Appleby PN, Barnes I, Reeves GK). Endogenous sex hormones and breast cancer in postmenopausal women: re-analysis of nine prospective studies. J Natl Cancer Inst 2002;94:606-16.
4. Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. J Natl Cancer Inst 2004;96:1856-65. (Pubitemid 40081323)
5. Kaaks R, Rinaldi S, Key TJ, Berrino F, Peeters PH, Biessy C, et al. Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr Relat Cancer 2005;12:1071-82. (Pubitemid 41815798)
6. Baglietto L, Severi G, English DR, Krishnan K, Hopper JL, McLean C, et al. Circulating steroid hormone levels and risk of breast cancer for postmenopausal women. Cancer Epidemiol Biomarkers Prev 2010;19:492-502.
7. Thomas HV, Key TJA, Allen DS, Moore JW, Dowsett M, Fentiman IS, et al. A prospective study of endogenous serum hormone concentrations and breast cancer risk in postmenopausal women on the island of Guernsey. B J Cancer 1997;76:401-5. (Pubitemid 27308094)
8. Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D, Million Women Study Collaboration. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ 2007;335:1134.
9. Siiteri PK, Hammond GL, Nisker JA. Increased availability of serum estrogens in breast cancer: a new hypothesis. In: Pike MC, Siiteri PK, Welsch CW, editors. Banbury Report 8. Hormones and Breast Cancer. Cold Spring Harbor Laboratory: New York; 1981. p. 87-106.
10. Endogenous Hormones and Breast Cancer Collaborative Group (Writing Committee: TJ Key, PN Appleby, GK Reeves, A Roddam). Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst 2003;95:1218-26.
11. Haiman CA, Dossus L, Setiawan VW, Stram DO, Dunning AM, Thomas G, et al. Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal women. Cancer Res 2007;67:1893-7. (Pubitemid 46424203)
12. Zeleniuch-Jacquotte A, Toniolo P, Levitz M, Shore RE, Koenig KL, Banerjee S, et al. Endogenous estrogens and risk of breast cancer by estrogen receptor status: a prospective study in postmenopausal women. Cancer Epidemiol Biomarkers Prev 1995;4:857-60.
13. Sieri S, Krogh V, Bolelli G, Abagnato CA, Grioni S, Pala V, et al. Sexhormonelevels, breast cancer risk, and cancer receptor status in postmenopausal women: the ORDET cohort. Cancer Epidemiol Biomarkers Prev 2009;18:169-76.
14. Helzlsouer KJ, Alberg AJ, Bush TL, Longcope C, Gordon GB, Comstock GW. A prospective study of endogenous hormones and breast cancer. Cancer Detect Prev 1994;18:79-85. (Pubitemid 2077549)
15. Rosenberg CR, Pasternack BS, Shore RE, Koenig KL, Toniolo PG. Premenopausal estradiol levels and the risk of breast cancer: a new method of controlling for day of the menstrual cycle. Am J Epidemiol 1994;140:518-25. (Pubitemid 24285934)
16. Thomas HV, Key TJ, Allen DS, Moore JW, Dowsett M, Fentiman IS, et al. A prospective study of endogenous serum hormone concentrations and breast cancer risk in premenopausal women on the island of Guernsey. Br J Cancer 1997;75:1075-9. (Pubitemid 27122629)
17. Kabuto M, Akiba S, Stevens RG, Neriishi K, Land CE. A prospective study of estradiol and breast cancer in Japanese women. Cancer Epidemiol Biomarkers Prev 2000;9:575-9. (Pubitemid 30396179)
18. Micheli A, Muti P, Secreto G, Krogh V, Meneghini E, Venturelli E, et al. Endogenous sex hormones and subsequent breast cancer in premenopausal women. Int J Cancer 2004;112:312-8. (Pubitemid 39244371)
19. Kaaks R, Berrino F, Key T, Rinaldi S, Dossus L, Biessy C, et al. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst 2005;97:755-65. (Pubitemid 40879595)
20. Eliassen AH, Missmer SA, Tworoger SS, Spiegelman D, Barbieri RL, Dowsett M, et al. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. J Natl Cancer Inst 2006;98:1406-15. (Pubitemid 44530717)
21. Tworoger SS, Eliassen AH, Sluss P, Hankinson SE. A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer. J Clin Oncol 2007;25:1482-8. (Pubitemid 46733075)
22. Endogenous Hormones and Breast Cancer Collaborative GroupKey TJ, Appleby PN, Reeves GK, Roddam AW. Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol 2010;11:530-42.
23. Bulun SE, Lin Z, Zhao H, Lu M, Amin S, Reierstad S, et al. Regulation of aromatase expression in breast cancer tissue. Ann N Y Acad Sci 2009;1155:121-31.
24. Miller WR. Aromatase and the breast: regulation and clinical aspects. Maturitas 2006;54:335-41.
25. Lee JS, Ettinger B, Stanczyk FZ, Vittinghoff E, Hanes V, Cauley JA, et al. Comparison of methods to measure low serum estradiol levels in postmenopausal women. J Clin Endocrinol Metab 2006;91:3791-7. (Pubitemid 44536845)
26. Ziegler RG, Faupel-Badger JM, Sue LY, Fuhrman BJ, Falk RT, Boyd-Morin J, et al. A new approach to measuring estrogen exposure and metabolism in epidemiologic studies. J Steroid Biochem Mol Biol 2010;121:538-45.